• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索纳米颗粒作为药物递送载体设计的影响因素。

Exploring Factors for the Design of Nanoparticles as Drug Delivery Vectors.

作者信息

Castillo Paula M, Jimenez-Ruiz Aila, Carnerero Jose M, Prado-Gotor Rafael

机构信息

Physical Chemistry Department. Faculty of Chemistry, University of Seville, C/Prof. García González, s/n, 41012, Sevilla, Spain.

出版信息

Chemphyschem. 2018 Nov 5;19(21):2810-2828. doi: 10.1002/cphc.201800388. Epub 2018 Aug 30.

DOI:10.1002/cphc.201800388
PMID:30102468
Abstract

To achieve optimal results when employing nanoparticles in biomedical fields, choosing the right type of nanoparticle and determining the correct procedure for drug loading are key factors. Each type of nanoparticle presents a determined set of characteristics that are, in some cases, unique. In general, their surface charge, geometry or hydrophilic character may be limiting factors, depending on what their intended application is. Once synthesized, additional factors, such as their interaction with biological systems and liberation mechanisms into the target cells, also need to be taken into account. Multiple advantages arise from the use of nanoparticles, such as the capability to solubilize hydrophobic compounds and an increased bioavailability. Those advantages justify the extensive and delicate study that should be undertaken in order to use them as drug delivery agents. One of the most important factors for the design of a drug delivery system with nanoparticles is achieving a high drug-to-nanoparticle ratio. In this Minireview, all of these key factors, both physicochemical and biological, are described, and special emphasis is placed on loading methods employed to introduce drugs into nanoparticles.

摘要

要在生物医学领域使用纳米颗粒时获得最佳效果,选择合适类型的纳米颗粒并确定正确的载药程序是关键因素。每种类型的纳米颗粒都具有一系列特定的特性,在某些情况下是独一无二的。一般来说,它们的表面电荷、几何形状或亲水性可能是限制因素,这取决于其预期应用。一旦合成,还需要考虑其他因素,例如它们与生物系统的相互作用以及向靶细胞的释放机制。使用纳米颗粒有多个优点,例如能够溶解疏水化合物并提高生物利用度。这些优点证明了为将它们用作药物递送剂而应进行的广泛而细致的研究是合理的。设计纳米颗粒药物递送系统最重要的因素之一是实现高药物与纳米颗粒比例。在这篇微型综述中,描述了所有这些物理化学和生物学关键因素,并特别强调了用于将药物引入纳米颗粒的载药方法。

相似文献

1
Exploring Factors for the Design of Nanoparticles as Drug Delivery Vectors.探索纳米颗粒作为药物递送载体设计的影响因素。
Chemphyschem. 2018 Nov 5;19(21):2810-2828. doi: 10.1002/cphc.201800388. Epub 2018 Aug 30.
2
Drug Encapsulated Nanoparticles for Treating Targeted Cells.用于治疗靶向细胞的药物封装纳米颗粒。
Curr Med Chem. 2017;24(30):3310-3321. doi: 10.2174/0929867324666170502122444.
3
Cellular and Molecular Targeted Drug Delivery: Nanochemistry in Medical Theranostics.细胞与分子靶向药物递送:医学诊疗中的纳米化学
Curr Top Med Chem. 2020;20(27):2425-2426. doi: 10.2174/156802662027201014152538.
4
The importance of nanoparticle shape in cancer drug delivery.纳米颗粒形状在癌症药物递送中的重要性。
Expert Opin Drug Deliv. 2015 Jan;12(1):129-42. doi: 10.1517/17425247.2014.950564. Epub 2014 Aug 20.
5
Improved Targeting of Cancers with Nanotherapeutics.利用纳米疗法改善癌症靶向治疗
Methods Mol Biol. 2017;1530:13-37. doi: 10.1007/978-1-4939-6646-2_2.
6
Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.纳米壳聚糖粒子在抗癌药物输送中的应用:最新综述。
Mini Rev Med Chem. 2017;17(15):1457-1487. doi: 10.2174/1389557517666170228105731.
7
Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.定制介孔硅纳米颗粒用于药物控释:平台制备、靶向递送、计算设计与分析。
Mini Rev Med Chem. 2018;18(11):976-989. doi: 10.2174/1389557516666160505114814.
8
Redox-responsive nano-carriers as tumor-targeted drug delivery systems.氧化还原响应性纳米载体作为肿瘤靶向药物传递系统。
Eur J Med Chem. 2018 Sep 5;157:705-715. doi: 10.1016/j.ejmech.2018.08.034. Epub 2018 Aug 13.
9
Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives.前列腺癌的纳米粒子治疗:概述与展望。
Curr Top Med Chem. 2019;19(1):57-73. doi: 10.2174/1568026619666190125145836.
10
Role of integrated cancer nanomedicine in overcoming drug resistance.整合癌症纳米医学在克服药物耐药性中的作用。
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1784-802. doi: 10.1016/j.addr.2013.07.012. Epub 2013 Jul 21.

引用本文的文献

1
Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.用于生物医学应用的放射性标记纳米材料:纳米技术时代的放射性药物学。
EJNMMI Radiopharm Chem. 2022 Apr 25;7(1):8. doi: 10.1186/s41181-022-00161-4.
2
Assisted delivery of anti-tumour platinum drugs using DNA-coiling gold nanoparticles bearing lumophores and intercalators: towards a new generation of multimodal nanocarriers with enhanced action.使用带有发光体和嵌入剂的DNA缠绕金纳米颗粒辅助递送抗肿瘤铂类药物:迈向新一代具有增强作用的多模态纳米载体。
Chem Sci. 2019 Aug 13;10(40):9244-9256. doi: 10.1039/c9sc02640a. eCollection 2019 Oct 28.